Cong B, Hou C, Shan C, Sun S, et al. Patient-reported outcomes of adjuvant therapy with CDK4/6 inhibitors for HR+/HER2- early breast cancer: a retrospective cohort study. BMC Cancer 2026 Apr 11. doi: 10.1186/s12885-026-15983.
PMID: 41965632